Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group

Contrib Nephrol. 1991:88:81-6; discussion 87-9.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anemia / drug therapy*
  • Double-Blind Method
  • Erythropoietin / therapeutic use*
  • Female
  • Hemoglobins / analysis
  • Humans
  • Kidney Failure, Chronic / drug therapy*
  • Kidney Failure, Chronic / psychology
  • Male
  • Middle Aged
  • Quality of Life*
  • Recombinant Proteins / therapeutic use

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin